Skip to main content
Clinical Trials/ITMCTR2100004931
ITMCTR2100004931
Recruiting
Phase 1

Clinical study on the treatment of renal colic with Qiu acupoint acupressure, an appropriate technique of traditional Chinese medicine

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\.Consistent with the following symptoms and signs:
  • (1\) Sudden onset of abdominal pain and discomfort;
  • (2\) When the attack physical examination of the affected side of the kidney area may have tenderness or percussion pain;
  • (3\) The pain may be accompanied by pallor, weakness, nausea and vomiting, sweating, etc.;
  • (4\) Digestive tract reaction (nausea and vomiting, dry mouth);
  • (5\) Perineal radiating pain;
  • (6\) Urinary irritation symptoms (frequency, urgency and pain);
  • (7\) Anorectal stimulation (frequent bowel movement, tenesmus);
  • (8\) Today hematuria (mirror or naked eyes), often after the activity;
  • Above symptom (1\), (2\)is necessary condition;

Exclusion Criteria

  • 1\. Delirious, mentally ill, with other serious diseases, unable to cooperate with the treatment of the patient;
  • 2\. Women during pregnancy, pregnancy and lactation;
  • 3\. Local skin is broken or ulcerated;, with severe primary diseases of viscera and other systems, and with severe urinary tract infection in urgent need of anti\-infection treatment;
  • 4\. Allergy to non\-steroidal anti\-inflammatory drugs, previous history of gastrointestinal bleeding or active gastric ulcer, and relevant contraindications prohibited in the drug instructions;
  • 5\. Oral history of taking calcium ion blocker and alpha blocker within 4 days before enrollment;
  • 6\. Patients with poor treatment compliance;
  • 7\. Previous patients with severe cardiovascular and cerebrovascular diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials